Rodica Stancou

1.1k total citations
17 papers, 935 citations indexed

About

Rodica Stancou is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Rodica Stancou has authored 17 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 5 papers in Oncology. Recurrent topics in Rodica Stancou's work include Cancer-related Molecular Pathways (5 papers), Cell death mechanisms and regulation (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Rodica Stancou is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cell death mechanisms and regulation (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Rodica Stancou collaborates with scholars based in France, Poland and Belgium. Rodica Stancou's co-authors include Jacques Bertoglio, Paul Lang, Franck Gesbert, M. Pouchelet, Salem Chouaı̈b, Zhenzi Cai, Gérard Gâcon, Olivier Dorseuil, Ali Bettaı̈eb and J. Masliah and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Rodica Stancou

17 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodica Stancou France 13 613 202 196 166 108 17 935
Michael Loubtchenkov Finland 7 558 0.9× 172 0.9× 102 0.5× 155 0.9× 74 0.7× 9 850
Raudel Sandoval United States 13 504 0.8× 184 0.9× 137 0.7× 227 1.4× 110 1.0× 15 1.0k
Borislav Stoyanov Germany 6 582 0.9× 183 0.9× 101 0.5× 152 0.9× 74 0.7× 8 808
Michele Pallaoro Italy 10 1.2k 2.0× 246 1.2× 319 1.6× 118 0.7× 75 0.7× 12 1.5k
Clare M. Heyworth United Kingdom 19 776 1.3× 331 1.6× 237 1.2× 143 0.9× 50 0.5× 35 1.3k
Neil A. Taylor United Kingdom 12 580 0.9× 179 0.9× 275 1.4× 320 1.9× 110 1.0× 15 1.1k
Pascale C. van Weeren Netherlands 11 842 1.4× 199 1.0× 178 0.9× 111 0.7× 44 0.4× 11 1.3k
Corinne Leprince France 16 558 0.9× 373 1.8× 109 0.6× 249 1.5× 119 1.1× 28 1.1k
Kristin Roovers United States 6 966 1.6× 126 0.6× 310 1.6× 284 1.7× 160 1.5× 7 1.3k
J. Ann Le Good Switzerland 12 1.4k 2.2× 176 0.9× 188 1.0× 283 1.7× 71 0.7× 12 1.7k

Countries citing papers authored by Rodica Stancou

Since Specialization
Citations

This map shows the geographic impact of Rodica Stancou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodica Stancou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodica Stancou more than expected).

Fields of papers citing papers by Rodica Stancou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodica Stancou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodica Stancou. The network helps show where Rodica Stancou may publish in the future.

Co-authorship network of co-authors of Rodica Stancou

This figure shows the co-authorship network connecting the top 25 collaborators of Rodica Stancou. A scholar is included among the top collaborators of Rodica Stancou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodica Stancou. Rodica Stancou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Thiery, Jérôme, Guillaume Dorothée, Hédi Haddada, et al.. (2003). Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function. The Journal of Immunology. 170(12). 5919–5926. 26 indexed citations
2.
Ameyar‐Zazoua, Maya, Nathanaël Larochette, Guillaume Dorothée, et al.. (2002). Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria. Cancer Gene Therapy. 9(3). 219–227. 21 indexed citations
3.
Blesson, Séverine, Jérôme Thiery, Catherine Gaudin, et al.. (2002). Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. International Immunology. 14(10). 1169–1178. 30 indexed citations
4.
Mami‐Chouaib, Fathia, Maya Ameyar, Guillaume Dorothée, et al.. (2001). Effect of nuclear factor κB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic function. European Journal of Immunology. 31(2). 433–439. 4 indexed citations
5.
Шатров, В. А., Maya Ameyar, Céline Bouquet, et al.. (2000). Adenovirus-mediated wild-type-p53-gene expression sensitizes TNF-resistant tumor cells to TNF-induced cytotoxicity by altering the cellular redox state. International Journal of Cancer. 85(1). 93–97. 22 indexed citations
6.
Ameyar, Maya, В. А. Шатров, Céline Bouquet, et al.. (1999). Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb. Oncogene. 18(39). 5464–5472. 32 indexed citations
7.
Ameyar, Maya, Azeddine Atfi, Zhenzi Cai, et al.. (1998). Analysis of Human Breast Adenocarcinoma MCF7 Resistance to Tumor Necrosis Factor-induced Cell Death. Journal of Biological Chemistry. 273(44). 29002–29008. 20 indexed citations
8.
Cai, Zhenzi, Ali Bettaı̈eb, Luc Legrès, et al.. (1997). Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α-mediated Cytotoxicity. Journal of Biological Chemistry. 272(11). 6918–6926. 92 indexed citations
9.
Cai, Zhenzi, Rodica Stancou, Marie Körner, & Salem Chouaı̈b. (1996). Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. International Journal of Cancer. 68(4). 535–546. 42 indexed citations
10.
Lang, Paul, et al.. (1996). Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes.. The EMBO Journal. 15(3). 510–519. 484 indexed citations
11.
Guizani-Tabbane, Lamia, Philipp A. Lang, Rodica Stancou, & Jacques Bertoglio. (1993). Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.. PubMed. 12(1). 25–32. 4 indexed citations
12.
Lang, Paul, Lamia Guizani-Tabbane, Rodica Stancou, et al.. (1992). ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity.. Journal of Biological Chemistry. 267(17). 11677–11680. 77 indexed citations
13.
Reibel, Louise, Olivier Dorseuil, Rodica Stancou, Jacques Bertoglio, & Gérard Gâcon. (1991). A hemopoietic specific gene encoding a small GTP binding protein is overexpressed during T cell activation. Biochemical and Biophysical Research Communications. 175(2). 451–458. 43 indexed citations
14.
Stancou, Rodica, et al.. (1990). Functional consequences of cAMP accumulation in human natural killer cells. Implications for IL-2 and IL-4 signal transduction.. The Journal of Immunology. 145(12). 4272–4278. 19 indexed citations
15.
Bertoglio, Jacques, et al.. (1989). Expression and regulation of interleukin-1 mRNA and interleukin-1 receptors in human B-cell lines.. PubMed. 4(3). 139–47; discussion 148. 2 indexed citations
16.
Hatzfeld, Jacques, Christiane Charriaut‐Marlangue, Jean-Pierre Lévesque, et al.. (1987). Le C3 stimule la prolifération des cellules humaines pré-B de la lignée Raji. Annales de l Institut Pasteur Immunologie. 138(3). 451–455. 14 indexed citations
17.
Stancou, Rodica, et al.. (1984). Possible role of sialic acid and endogenous neuraminidase in T-cell proliferation. Cell Biology International Reports. 8(8). 637–647. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026